Ravi Rao April 8, 2026 GLP-1 receptor agonists, widely used for type 2 diabetes and weight management, often cause gastrointestinal side effects that clinicians must address proactively
The mechanism by which metformin augments GLP-1 responses is not entirely clear
Arizona, Arkansas, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Jersey, New Hampshire, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Virginia, Vermont, Washington, West Virginia, Wisconsin, Wyoming.
They are synergistic
Youll also get access to quick-reference tools for counseling and clinical decision-making, including: GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison Chart Diabetes Medications: Cardiovascular and Kidney Impact Protein Content of Common Food s Vitamin D-Rich Foods Product Goals Upon completion of the GLP-1 Essentials training, you will be able to: Explain the mechanisms, indications, and safety profiles of GLP-1 receptor agonists
